UK Markets closed

Swedish Orphan Biovitrum AB (publ) (SOBI.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
222.00+0.80 (+0.36%)
At close: 05:29PM CEST
Sign in to post a message.
  • M
    Mothra
    Without a doubt LPI goes above $200 if Oil goes to $175 like Hurricane Dimon says.........Have a Great Weekend everyone. I Know I will!
  • I
    Ioneer Ticker IONR
    Swedish Orphan Biovitrum : Advent and Aurora Investment offers to buy Sweden's SOBI in $8- bln deal

    STOCKHOLM, Sept 2 (Reuters) - U.S. venture capital firm Advent International and Aurora Investment, an affiliate of capital market firm GIC, has offered to buy Swedish Orphan Biovitrum (SOBI) in a deal valuing it at about 69.4 billion Swedish crowns ($8 billion).

    SOBI said the two firms had offered 235 Swedish crowns ($27.3) for each share through Agnafit Bidco AB.

    Investors AB and Fjärde AP-Fonden, with SOBI stakes of about 36.45% and 6.96% respectively, have separately agreed to accept the offer, the company said, adding that its board had unanimously recommended that shareholders accept.

    SOBI said the offer price was a premium of about 34.5% to its Aug. 25 closing price of 174.70 crowns on Nasdaq Stockholm.

    "The board believes that the terms of the offer recognise SOBI’s long-term growth prospects, as well as the risks associated with those prospects, and provide certainty, in cash, to shareholders," it said. ($1=8.6178 Swedish crowns) (Reporting by Helena Soderpalm; Editing by Clarence Fernandez)
  • H
    Haley
    STOCKHOLM , Dec. 9, 2019 /PRNewswire/ -- Dova Pharmaceuticals, a wholly owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi™), presented additional analyses from the phase 3 study - core and extension phase - with avatrombopag (AVA) for the treatment of immune thrombocytop... In case you are interested https://marketwirenews.com/news-releases/additional-analyses-from-phase-3-study-with-doptelet-5543960958338332.html?i=y
    STOCKHOLM , Dec. 9, 2019 /PRNewswire/ -- Dova Pharmaceuticals, a wholly owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi™),.
    STOCKHOLM , Dec. 9, 2019 /PRNewswire/ -- Dova Pharmaceuticals, a wholly owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi™),.
    marketwirenews.com
  • b
    brendan
    What just happened?
  • M
    Mukund
    strong upwards trend
  • I
    Ioneer Ticker IONR
    By the way, you can buy Stock under ticker "SOBI" at ETORO trading.
  • I
    Ioneer Ticker IONR
    Luckily I sold alll my SOBI stock immediately after takeover was announced. Don't know why but had a feeling it wasn't going through. That said, nothing has changed as regards the Company and I wll get back on shortly I think. Have to see how their Covid therapy drug goes.
  • P
    Paula
    I get their Zaditen for asthma and Mast Cell Activation disorder - purchased via North Drug Store in Canada. The product is
    excellent - it works.